Position in SVTRnew
Snapshot 2026-11-05- Startup SignalsRankedof 2,340
- Life SciencesRankedof 248
- Healthcare ServicesRankedof 92
- Mental Health#6of 11
About
Siggy is a New York-based mental health startup where patients start with a free AI history-taking conversation before video visits with licensed clinicians, combining those answers with wearable data to produce a daily 'Siggy Score' that tracks progress between appointments.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 6
Founders / team· 2
Funding history
- 2026-11-05Pre-Seed$6M
Investors · Village Global, Union Square Ventures, Coalition Operators, PsyMed Ventures, Mystic Ventures, Immad AkhundSource · webwire.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Siggy
Siggy is a New York-based mental health startup where patients start with a free AI history-taking conversation before video visits with licensed clin…
Pre-Seed · $6M · 2026-11
$6M
United States
BusinessLatest roundTotal raisedDate- Goodpath
AI virtual care for weight management, musculoskeletal pain, diabetes, digestive health, sleep, mental health, cancer recovery and more
Series A · $18M · 2025-09
$18M - Handspring
Operates a virtual clinic offering personalized mental health treatment for children, adolescents and families
Series A · $12M · 2025-06
$12M - FamilyWell Health
Virtual mental health care for women (from fertility through menopause)
Series A · $8M · 2025-11
$8M
Europe
BusinessLatest roundTotal raisedDate- Kyan Health
Platform providing personalized mental health and well-being support for employees and their families.
Undisclosed · $13M · 2024-11
$13M - Clare&me
AI mental health assistant offering 24/7 support via phone and WhatsApp messages
Undisclosed · $4M · 2024-08
$4M - Thymia
Develops gamified AI tools for mental health assessments
Seed · $3M · 2023-07
$3M
Other / unspecified
BusinessLatest roundTotal raisedDate- Mentaily
AI diagnostic tools that support mental health professionals with early detection and personalized assessment
Seed · $3M · 2025-05
$3M - LEESOL
Brainwave-synchronizing wearables for sleep and mental health (Sleepisol series, blissol, DAYZER) with AI biosignal analysis
Series A · $1.1B · 2026-02
$1.1B - Even Healthcare
Health subscription membership for individuals and businesses (unlimited consultations, free testing)…
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Y Combinator
39 Life Sciences deals in the last 24 months · 27 at a nearby stage · 32 in NYC Metro
Request intro →General Catalyst
38 Life Sciences deals in the last 24 months · 17 at a nearby stage · 34 in NYC Metro
Request intro →Andreessen Horowitz
22 Life Sciences deals in the last 24 months · 11 at a nearby stage · 20 in NYC Metro
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 7 at a nearby stage · 20 in NYC Metro
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 3 at a nearby stage · 15 in NYC Metro
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 5 at a nearby stage · 14 in NYC Metro
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.